The Antiepileptic Drug Oxcarbazepine Inhibits the Growth of Patient-Derived Isocitrate Dehydrogenase Mutant Glioma Stem-like Cells
Patients diagnosed with isocitrate dehydrogenase mutant (IDH<sup>mut</sup>) gliomas suffer frequently from seizures. Although the clinical course is less aggressive than that of its IDH wildtype counterpart, recent discoveries have shown that epileptic activity can promote tumor prolifer...
Main Authors: | Philip Dao Trong, Gerhard Jungwirth, Andreas Unterberg, Christel Herold-Mende, Rolf Warta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/8/1200 |
Similar Items
-
Large-Scale Drug Screening in Patient-Derived IDH<sup>mut</sup> Glioma Stem Cells Identifies Several Efficient Drugs among FDA-Approved Antineoplastic Agents
by: Philip Dao Trong, et al.
Published: (2020-06-01) -
Stochastic Microsensors Based on Carbon Nanotubes for Molecular Recognition of the Isocitrate Dehydrogenases 1 and 2
by: Raluca-Ioana Stefan-van Staden, et al.
Published: (2022-01-01) -
IMPACT OF ANTIEPILEPTIC DRUGS ON COGNITIVE FUNCTIONS: FOCUS ON PERAMPANEL
by: E. D. Belousova
Published: (2016-12-01) -
The efficacy and safety of novel antiepileptic drugs in treatment of epilepsy of patients with brain tumors
by: Weiwei Zhai, et al.
Published: (2024-03-01) -
Biochemical Characterization of Recombinant Isocitrate Dehydrogenase and Its Putative Role in the Physiology of an Acidophilic Micrarchaeon
by: Dennis Winkler, et al.
Published: (2021-11-01)